Bulygina, V.V.
224  results:
Search for persons X
?
2

P.0578 Chemogenetic activation of glutamatergic neurons in ..:

Dygalo, N. ; Drozd, U.S. ; Bulygina, V.V....
European Neuropsychopharmacology.  53 (2021)  - p. S424 , 2021
 
?
4

P.111 Subanesthetic dose of ketamine relieves depression-li..:

Dygalo, N. ; Drozd, U.S. ; Kalinina, T.S....
European Neuropsychopharmacology.  29 (2019)  - p. S94 , 2019
 
?
6

Ketamine improves depressive symptoms caused by stress and ..:

Dygalo, N. ; Drozd, U.S. ; Kalinina, T.S....
European Neuropsychopharmacology.  29 (2019)  - p. S212 , 2019
 
?
 
?
 
?
10

Otogenetic activation of the CA1 hippocampal pyramidal neur..:

Dygalo, N. ; Lanshakov, D.A. ; Drozd, U.S....
European Neuropsychopharmacology.  26 (2016)  - p. S277-S278 , 2016
 
?
12

P.1.f.004 Behavioural and neurodevelopmental effects of ACT..:

Dygalo, N. ; Kalinina, T.S. ; Shemenkova, T.V....
European Neuropsychopharmacology.  21 (2011)  - p. S327-S328 , 2011
 
?
14

Prolonged Social Isolation and Social Instability in Adoles..:

Maslova, L. N. ; Bulygina, V. V. ; Amstislavskaya, T. G.
Neuroscience and Behavioral Physiology.  40 (2010)  9 - p. 955-963 , 2010
 
?
15

Immunohistochemical Analysis of Active Caspase-3 Expression..:

Lanshakov, D. A. ; Bulygina, V. V. ; Romanova, I. V..
Bulletin of Experimental Biology and Medicine.  147 (2009)  5 - p. 635-638 , 2009
 
1-15